digiMedical Solutions, Inc. Introduces digiRXComp(TM) 3.0 to Digitally Manage and Transmit Workmen's Compensation Data From Physician to Pharmacy
Posted on: Tuesday, 10 April 2007, 09:00 CDT
digiMedical Solutions, Inc.™ (OTC:DGMS) today announced the introduction of the company's latest digital prescription handling software product digiRXComp™ 3.0. digiRXComp™ 3.0 has been developed to digitally transmit the patient's workmen's compensation data, in conjunction with the patient's prescription, from the physician to any company-owned pharmacy for significantly expedited prescription fulfillment. digiRXComp™ 3.0 is designed to streamline medical practice processes and to eliminate the overhead of processing Workmen's Compensation prescriptions in both the physician's office or clinic and the pharmacy. The new software captures the workmen's compensation data required by law at the physician's location and transmits this data directly to any company-owned pharmacy. This new process eliminates re-collection of data at the pharmacy, eliminates pharmacist call-backs to physicians and, in extreme cases, eliminates the need for patients to re-visit the physician to collect their case file. digiRXComp™ 3.0 is the latest software product in a suite of digital prescription handling software offered by digiMedical.
digiMedical has partnered with medAlert Occupational to develop digiRXComp™ 3.0, and medAlert is the first customer to use the new software. medALERT Occupational is a full service occupational medicine provider serving private, public, and government employers, as well as most private insurances in the Dallas/Fort Worth Metroplex. digiMedical Solutions will continue to target the Occupational Medicine market with this new software service in the coming months.
Jose G. Trevino, M.D. of medALERT states, "digiMedical Solutions has become a valued partner in our medical practice. They provide us expertise in technology that we haven't been able to find elsewhere. With the new digiRXComp™ 3.0 to manage Workmens' Compensation, we can electronically send all prescription requests to the pharmacy and eliminate time consuming office practices. It also reinforces to my staff that we now share information with our partners, and the information must be timely and accurate so our patients can receive even better service than we provide today. We also want to find ways to work with digiMedical Solutions to jointly market our services."
digiMedical Solutions is a Microsoft (NasdaqGS:MSFT) Independent Software Vendor (ISV) and has built digiRXComp™ 3.0 on the new .NET Framework 3.0 architecture and leverages a SQL Server 2005 64-bit database environment.
About digiMedical Solutions, Inc.(tm) (www.digiMedical.com)
digiMedical Solutions, Inc.(tm) is a pharmacy and medical technology company focused on developing next generation, digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless based d-prescription technology to physicians, acquisition of independent pharmacy chains and the sale of select territories to "market partners" licensed to exploit the digiMedical Solutions(tm) model. digiMedical Solutions, Inc.™ currently owns and operates six pharmacies throughout Texas and Florida and is a Microsoft (NasdaqGS:MSFT) Independent Software Vendor (ISV). digiMedical Solutions™ unique business model connects physicians, patients and pharmacies with next generation medical technologies.
Forward-Looking Statement
Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including "anticipate,""await,""envision,""foresee,""aim at,""believe,""intends,""estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.
Source: Business Wire
Related Articles
- Micros Report Initiates Research Coverage on digiMedical Solutions, Inc., With Fair Value Target Price of $0.30 or Potentially Higher Vs. Recent Close of $0.09
- digiMedical Solutions, Inc.'s Proprietary Pharmacy Technology, digiRX, Helps Company Reduce Operating Costs By Over $25,000 Per Month
- DigiMedical Solutions, Inc.(TM) Announces Contract With Naples Cardiologist Specialists for DigiRX(TM) Digital Prescription Technology and DigiReAuth(TM) Full-Service Call Center Services
- digiMedical Solutions Inc. Upgrades digiRX(TM) 2.0 to Transmit Off-Network Prescriptions at a Rate of Over a 200 Per Minute
- digiMedical Solutions, Inc.(TM) Announces New Pharmacist-in-Charge for Company Owned Harrington's Pharmacy in Ft. Myers, Florida
- digiMedical Solutions, Inc. (TM) Interview of CEO On Market News First Available on New Company Website
- digiMedical Solutions, Inc.(TM) Announces New Pharmacist-In-Charge for the Company's Largest Dallas-Based Pharmacy, The Apothecary Shop
- digiMedical Solutions, Inc.(TM) Successfully Launches digiRxStream(TM) to Provide Schedule II Controlled Substance Drug Prescription Handling for Physician Offices
- digiMedical Solutions, Inc.(TM) Appoints Susanne Myler As Vice President of Pharmacy Chain Operations and Compliancy
User Comments (0)

RSS Feeds